COVID-19 vaccine effectiveness updates - 24 February 2023 (CDC)

URL

Authors

Amadea Britton

Published Date

February 24, 2023

Organization

CDC (Centers for Disease Control & Prevention)

Key Excerpts

"Organization of presentation

Preliminary vaccine effectiveness (VE) of monovalent vaccines against symptomatic infection in children aged 6 months-4 years (Pfizer-BioNTech) and 6 months-5 years (Modern)
Update on VE of bivalent vaccines against symptomatic infection in children aged 5-17 years and adults aged ≥18 years
Update on VE of bivalent vaccines against severe disease in adults with a focus on adults aged ≥65 years"

Relative bivalent VE against hospitalization ages 18-64

Relative bivalent VE against hospitalization ages 65 and over

Medium

document

Topics

COVID-19,hospitalizations,vaccines